Completed NA INTERVENTIONAL 2-arm NCT02017782

Controlled Human Exposure to Indoor Air, Dust and Ozone (XDOZ)

Sponsor: University of Aarhus

Conditions Acute Changes in Cardiovascular Outcomes Acute Changes in Respiratory Outcomes Changes in Biomarkers General Mucosal Irritation Subjective Discomfort

Interventions Dust Dust and Ozone Ozone Placebo (Filtered air)

Updated 5 times since 2017 Last updated: Dec 16, 2013 Started: Apr 30, 2013 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Changes in Cardiovascular Outcomes and Acute Changes in Respiratory Outcomes and is currently completed. University of Aarhus leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Aarhus

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark